Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frequency-Domain Transformation of cfDNA End-Motif Profiles Enhances Robust Cancer Detection.

Genes·2026
Same author

Occupancy-based mechanism is the chief mode of ROS1 function in preventing DNA hypermethylation.

Nature plants·2026
Same author

Multi-to-uni modal knowledge transfer pre-training for molecular representation learning.

Nature communications·2026
Same author

Early cancer detection via multi-omics cfDNA fragmentation using early-late fusion neural network with sample-modality evaluation.

Briefings in bioinformatics·2025
Same author

Pore-C Pipeline-Toolbox: a comprehensive pipeline for Pore-C data analysis.

Briefings in bioinformatics·2025
Same author

Multi-Modality Sheep Face Recognition Based on Deep Learning.

Animals : an open access journal from MDPI·2025

Related Experiment Video

Updated: Jan 15, 2026

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

10.5K

cfMethDB: A Comprehensive cfDNA Methylation Data Resource for Cancer Biomarkers.

Yuanhui Sun1,2, Zhixian Zhu1,2, Qiangwei Zhou1,2

  • 1National Key Laboratory of Crop Genetic Improvement, Hubei Hongshan Laboratory, Huazhong Agricultural University, Wuhan 430070, China.

Genomics, Proteomics & Bioinformatics
|October 15, 2025
PubMed
Summary
This summary is machine-generated.

A new database, cfMethDB, integrates cell-free DNA (cfDNA) methylation data from thousands of cancer studies. This resource aids in discovering novel cfDNA methylation biomarkers for early cancer detection and clinical applications.

Keywords:
BiomarkerDNA methylationDatabasePan-cancercfDNA

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.1K
Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

9.0K

Related Experiment Videos

Last Updated: Jan 15, 2026

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

10.5K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.1K
Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

9.0K

Area of Science:

  • Biochemistry
  • Genomics
  • Bioinformatics

Background:

  • Early cancer detection significantly improves patient outcomes.
  • DNA methylation in circulating cell-free DNA (cfDNA) shows promise as a non-invasive biomarker for cancer diagnosis.
  • Limited integration of existing cfDNA methylation data hinders biomarker discovery.

Purpose of the Study:

  • To develop cfMethDB, a comprehensive database for cfDNA methylation in cancer.
  • To standardize analysis of public cfDNA methylation datasets.
  • To identify novel cfDNA methylation biomarkers for cancer detection.

Main Methods:

  • Collected and integrated 4828 publicly available cfDNA methylation datasets.
  • Performed standardized analysis to identify differentially methylated cytosines (DMCs).
  • Developed user-friendly tools for biomarker evaluation and pan-cancer analysis.

Main Results:

  • Identified 1,048,770 DMCs as candidate biomarkers across seven cancer types.
  • Validated known cfDNA methylation biomarkers.
  • Discovered potential novel biomarkers, including the gene ZIC4.
  • cfMethDB provides tools for biomarker evaluation, pan-cancer search, and end motif analysis.

Conclusions:

  • cfMethDB serves as a valuable platform for discovering novel cancer cfDNA methylation biomarkers.
  • The database facilitates advancements in cancer research and clinical applications.
  • Standardized analysis of cfDNA methylation data is crucial for biomarker discovery.